"Osteosarcoma" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Descriptor ID |
D012516
|
| MeSH Number(s) |
C04.557.450.565.575.650 C04.557.450.795.620
|
| Concept/Terms |
Osteosarcoma- Osteosarcoma
- Osteosarcomas
- Osteosarcoma Tumor
- Osteosarcoma Tumors
- Tumor, Osteosarcoma
- Tumors, Osteosarcoma
- Sarcoma, Osteogenic
- Osteogenic Sarcomas
- Sarcomas, Osteogenic
- Osteogenic Sarcoma
|
Below are MeSH descriptors whose meaning is more general than "Osteosarcoma".
Below are MeSH descriptors whose meaning is more specific than "Osteosarcoma".
This graph shows the total number of publications written about "Osteosarcoma" by people in this website by year, and whether "Osteosarcoma" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 1 | 3 |
| 1997 | 2 | 2 | 4 |
| 1998 | 0 | 3 | 3 |
| 1999 | 1 | 1 | 2 |
| 2000 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2003 | 3 | 1 | 4 |
| 2004 | 3 | 0 | 3 |
| 2005 | 2 | 0 | 2 |
| 2006 | 1 | 0 | 1 |
| 2007 | 3 | 0 | 3 |
| 2008 | 4 | 2 | 6 |
| 2009 | 5 | 0 | 5 |
| 2010 | 4 | 1 | 5 |
| 2011 | 3 | 0 | 3 |
| 2012 | 3 | 1 | 4 |
| 2013 | 2 | 0 | 2 |
| 2014 | 8 | 0 | 8 |
| 2015 | 9 | 2 | 11 |
| 2016 | 6 | 0 | 6 |
| 2017 | 4 | 1 | 5 |
| 2018 | 3 | 1 | 4 |
| 2019 | 5 | 1 | 6 |
| 2020 | 5 | 0 | 5 |
| 2021 | 6 | 1 | 7 |
| 2022 | 7 | 0 | 7 |
| 2023 | 5 | 0 | 5 |
| 2024 | 8 | 1 | 9 |
| 2025 | 5 | 0 | 5 |
To return to the timeline,
click here.
Below are the most recent publications written about "Osteosarcoma" by people in Profiles.
-
A Spatiotemporal Model of CXCL10 as a Master Regulator of Immune Evasion and Metastasis in Osteosarcoma. Int J Mol Sci. 2025 Dec 27; 27(1).
-
Cytohistologic Diagnosis of Rosette-Forming Epithelioid Osteosarcoma. Diagn Cytopathol. 2026 Mar; 54(3):E63-E66.
-
Nutrition Support Interventions for Children and Young People Treated for Osteosarcoma: A Scoping Review. J Hum Nutr Diet. 2025 Dec; 38(6):e70172.
-
Transphyseal tumor extension on initial magnetic resonance imaging (MRI) correlates with metastases in pediatric extremity osteosarcoma. Skeletal Radiol. 2026 Mar; 55(3):525-531.
-
Central memory-enriched V?9Vd2 ?d T cells via TGF-? expansion demonstrate enhanced in vivo efficacy against metastatic osteosarcoma. Front Immunol. 2025; 16:1657760.
-
Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement. J Natl Compr Canc Netw. 2024 Dec 27; 23(1).
-
Lenvatinib Plus Ifosfamide and Etoposide in Children and Young Adults With Relapsed Osteosarcoma: A Phase 2 Randomized Clinical Trial. JAMA Oncol. 2024 12 01; 10(12):1645-1653.
-
Contemporary surgical management of osteosarcoma and Ewing sarcoma. Pediatr Blood Cancer. 2025 Apr; 72 Suppl 2:e31374.
-
Intraoperative Bone Cement Implantation Syndrome in a Pediatric Patient: A Case Report. JBJS Case Connect. 2024 Oct 01; 14(4).
-
Intrinsic Epigenetic State of Primary Osteosarcoma Drives Metastasis. Mol Cancer Res. 2024 09 04; 22(9):864-878.